Dyspnea: The continuing challenge of palliative management

Current Opinion in Oncology

Volumn 14, Issue 4, 2002, Pages 394-398

  LeGrand, Susan B ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; MIDAZOLAM; MORPHINE; NARCOTIC AGENT;

ANXIETY; ASSISTED VENTILATION; BREATHING MUSCLE; DYSPNEA; HOSPITALIZATION; HUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; LUNG TUMOR; OXYGEN THERAPY; RESPIRATORY FAILURE; TERMINAL CARE;

DYSPNEA; HUMAN; LUNG NEOPLASMS; NARCOTICS; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; RESPIRATORY INSUFFICIENCY; TERMINAL CARE; HUMANS;

EID: 0035988121     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200207000-00004     Document Type: Review

References (36)

1. Is the presence of dyspnea a risk factor for morbidity in cancer patients?
2. A multicenter international study of sedation for uncontrolled symptoms in terminally ill patients
3. Dyspnea: Mechanisms, assessment, and management: A consensus statement
4. Neural substrates for the perception of acutely induced dyspnea
5. The sensation of breathlessness
6. Proprioceptive chest wall afferents and the effect on respiratory sensation
7. Effect of inspiratory muscle fatigue on perception of effort during loaded breathing
8. Dyspnea in the advanced cancer patient
9. Physiological changes and clinical correlations of dyspnea in cancer outpatients
10. The frequency and correlates of dyspnea in patients with advanced cancer
11. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis
12. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer
13. Distinguishable types of dyspnea in patients with shortness of breath
14. The language of breathlessness: Use of verbal descriptors by patients with cardiopulmonary disease
15. Descriptors of breathlessness in cardiorespiratory disease
16. Reliability and validity of dyspnea sensory quality descriptors in heart failure patients treated in the emergency department
17. Dyspnea in cancer patients: Prevalence and associated factors
18. Silicone stents in the management of inoperable tracheobronchial stenoses: Indications and limitations
19. Use of expandable wire stents for malignant airway obstruction
20. Symptomatic improvement in dyspnea following tracheobronchial metallic stenting for malignant airway obstruction
21. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion
22. A randomized comparison if indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions
23. Opioids for the palliation of breathlessness in terminal illness
24. Perspectives on care at the close of life: Management of dyspnea in patients with far-advancing lung disease: "once I lose it, it's kind of hard to catch it..."
25. Reduction in exercise lactic acidosis and ventilation as a result of exercise training in patients with chronic obstructive pulmonary disease
26. Non-pharmacological intervention for breathlessness in lung cancer
27. Effects of exercise on cancer-related fatigue
28. Terminal sedation in palliative medicine: Definition and review of the literature
29. Common symptoms in advanced disease
30. Chlorpromazine: A specific effect on breathlessness?
31. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy
32. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in chronic obstructive pulmonary disease
33. Respiratory muscle training in chronic airflow limitation: A meta-analysis
34. Cancer nursing practice development: Understanding breathlessness
35. Multicenter randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer
36. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life: A systematic review